|
Market Closed -
Nasdaq
07:00:00 14/10/26 am AEDT
|
After hours 10:52:34 am | |||
| 112.28 USD | -0.71% |
|
111.99 | -0.26% |
| 14/10 | CVS settles US Justice Department case over opioid prescriptions for $315 million | RE |
| 14/10 | Walmart to offer 250-plus free medications, including GLP-1s, to employees | RE |
Company Valuation: Walmart Inc.
Data adjusted to current consolidation scope
| Fiscal Period: January | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 387,816 | 387,989 | 444,892 | 788,557 | 949,566 | 897,148 | - | - |
| Change | - | 0.04% | 14.67% | 77.25% | 20.42% | -5.52% | - | - |
| Enterprise Value (EV) 1 | 415,887 | 423,986 | 481,916 | 825,310 | 990,362 | 948,425 | 949,212 | 951,027 |
| Change | - | 1.95% | 13.66% | 71.26% | 20% | -4.23% | 0.08% | 0.19% |
| P/E | 28.7x | 33.7x | 28.8x | 40.7x | 43.6x | 39x | 35.3x | 31.7x |
| PBR | 4.69x | 5.11x | 5.31x | 8.67x | 9.59x | 8.27x | 7.52x | 7.04x |
| PEG | - | -2.7x | 0.8x | 1.6x | 3.3x | 7.26x | 3.4x | 2.8x |
| Capitalization / Revenue | 0.68x | 0.64x | 0.69x | 1.17x | 1.34x | 1.19x | 1.14x | 1.09x |
| EV / Revenue | 0.73x | 0.7x | 0.75x | 1.22x | 1.4x | 1.26x | 1.21x | 1.16x |
| EV / EBITDA | 11.3x | 11.9x | 12.4x | 19.4x | 21.9x | 19.3x | 17.8x | 16.5x |
| EV / EBIT | 16x | 17.2x | 17.8x | 28x | 31.8x | 28.2x | 25.8x | 23.4x |
| EV / FCF | 37.6x | 35.4x | 31.9x | 65.2x | 66.4x | 80.6x | 58.8x | 51.5x |
| FCF Yield | 2.66% | 2.83% | 3.14% | 1.53% | 1.51% | 1.24% | 1.7% | 1.94% |
| Dividend per Share 2 | 0.7333 | 0.7467 | 0.76 | 0.83 | 0.94 | 0.9964 | 1.05 | 1.108 |
| Rate of return | 1.57% | 1.56% | 1.38% | 0.85% | 0.79% | 0.89% | 0.94% | 0.99% |
| EPS 2 | 1.623 | 1.423 | 1.913 | 2.41 | 2.73 | 2.877 | 3.179 | 3.542 |
| Distribution rate | 45.2% | 52.5% | 39.7% | 34.4% | 34.4% | 34.6% | 33% | 31.3% |
| Net sales 1 | 567,762 | 605,881 | 642,637 | 674,538 | 706,413 | 752,858 | 785,705 | 822,281 |
| EBITDA 1 | 36,708 | 35,547 | 38,865 | 42,477 | 45,185 | 49,157 | 53,269 | 57,770 |
| EBIT 1 | 26,050 | 24,602 | 27,012 | 29,504 | 31,096 | 33,658 | 36,815 | 40,716 |
| Net income 1 | 13,673 | 11,680 | 15,511 | 19,436 | 21,893 | 23,012 | 25,362 | 28,067 |
| Net Debt 1 | 28,071 | 35,997 | 37,024 | 36,753 | 40,796 | 51,277 | 52,064 | 53,879 |
| Reference price 2 | 46.60 | 47.96 | 55.08 | 98.16 | 119.14 | 112.28 | 112.28 | 112.28 |
| Nbr of stocks (in thousands) | 8,321,635 | 8,090,400 | 8,076,701 | 8,033,386 | 7,970,167 | 7,933,746 | - | - |
| Announcement Date | 17/2/22 | 21/2/23 | 20/2/24 | 20/2/25 | 19/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 39.31x | 1.26x | 19.29x | 0.88% | 897B | |
| 24.19x | 1.16x | 10.09x | 0.98% | 50.48B | |
| 16.3x | 0.57x | 8.27x | 3.16% | 42.1B | |
| 16.42x | 0.66x | 12.37x | 2.81% | 38.71B | |
| 12.42x | 0.34x | 6.44x | 2.4% | 36.95B | |
| 21.57x | 0.9x | 6.03x | 5.86% | 36.77B | |
| 26.68x | 0.83x | 9.6x | 2.76% | 33.16B | |
| 11.75x | 0.46x | 5.77x | 4% | 30.63B | |
| 16.16x | 0.63x | 7.2x | 2.97% | 28.44B | |
| 20.82x | 0.77x | 6.42x | 1.25% | 26.51B | |
| Average | 20.56x | 0.76x | 9.15x | 2.71% | 122.09B | |
| Weighted average by Cap. | 33.84x | 1.12x | 16.36x | 1.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WMT Stock
- Valuation Walmart Inc.
Select your edition
All financial news and data tailored to specific country editions
